Seres Therapeutics, Inc. - COM (MCRB)

Historical Portfolio Holders from Q2 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
63.4M
Holdings value Q3 2024
$60M
Value change Q3 2024
-$4.73M
Grand Portfolio weight change Q3 2024
0%
Number of holders
73
Number of buys Q3 2024
24
Number of sells Q3 2024
-48
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 63.4M $60M -$4.73M $0.95 74
2024 Q2 69.1M $50M -$12.2M $0.72 90
2024 Q1 85.6M $66.3M -$6.64M $0.77 94
2023 Q4 89.5M $125M -$44M $1.40 103
2023 Q3 107M $256M -$20.5M $2.38 135
2023 Q2 112M $538M +$33.9M $4.79 139
2023 Q1 105M $594M -$2.18M $5.67 124
2022 Q4 105M $588M +$1.17M $5.60 123
2022 Q3 105M $672M +$113M $6.42 116
2022 Q2 90.4M $310M +$47.5M $3.43 122
2022 Q1 75.5M $537M -$11.5M $7.12 128
2021 Q4 77.1M $643M -$22M $8.33 145
2021 Q3 65.1M $453M -$220M $6.96 127
2021 Q2 66.6M $1.58B -$105M $23.85 140
2021 Q1 74.8M $1.54B +$72.7M $20.59 149
2020 Q4 71.6M $1.76B +$156M $24.50 147
2020 Q3 85.9M $2.43B +$415M $28.31 116
2020 Q2 72M $342M +$20.3M $4.76 94
2020 Q1 67.8M $242M +$6.6M $3.57 74
2019 Q4 65.9M $227M +$4.75M $3.45 75
2019 Q3 64.3M $258M +$14.7M $4.01 74
2019 Q2 39.9M $128M +$60.6M $3.22 85
2019 Q1 21M $144M +$13.8M $6.87 77
2018 Q4 31.7M $143M -$2.23M $4.52 64
2018 Q3 19.3M $147M +$1.44M $7.59 68
2018 Q2 19.1M $165M -$2.87M $8.60 74
2018 Q1 32.3M $237M +$913K $7.34 77
2017 Q4 32.1M $325M +$13.2M $10.14 85
2017 Q3 18.1M $290M +$9.52M $16.04 78
2017 Q2 17.5M $198M -$3.66M $11.30 72
2017 Q1 30.5M $344M +$13M $11.27 78
2016 Q4 31.1M $308M -$7.89M $9.90 89
2016 Q3 31.2M $383M -$57.7M $12.29 92
2016 Q2 18.8M $547M +$54M $29.05 89
2016 Q1 30.9M $822M +$43.1M $26.56 76
2015 Q4 15.2M $533M +$51.1M $35.09 66
2015 Q3 13.8M $409M +$66M $29.64 59
2015 Q2 11.4M $471M +$471M $41.50 45